Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Operating Expenses (2016 - 2025)

China Pharma Holdings' Other Operating Expenses history spans 16 years, with the latest figure at $82313.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 53.11% year-over-year to $82313.0; the TTM value through Dec 2025 reached $374768.0, down 29.89%, while the annual FY2025 figure was $374768.0, 29.89% down from the prior year.
  • Other Operating Expenses reached $82313.0 in Q4 2025 per CPHI's latest filing, down from $103343.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $440734.0 in Q2 2021 to a low of $82313.0 in Q4 2025.
  • Average Other Operating Expenses over 5 years is $194479.6, with a median of $173953.5 recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: plummeted 78.75% in 2021, then surged 30.05% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $286280.0 in 2021, then grew by 23.75% to $354261.0 in 2022, then decreased by 24.35% to $267996.0 in 2023, then plummeted by 34.5% to $175527.0 in 2024, then tumbled by 53.11% to $82313.0 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Other Operating Expenses are $82313.0 (Q4 2025), $103343.0 (Q3 2025), and $103324.0 (Q2 2025).